Optimizing the use of CROs by academia and small companies

Rachel F. Lane; Lauren G. Friedman; Curtis Keith; Steven P. Braithwaite; Julie A. Frearson; David A. Lowe; Frank M. Longo; Lorenzo M. Refolo; D. Martin Watterson; Katya Tsaioun; Diana W. Shineman; Howard M. Fillit

doi:10.1038/nrd4057

Optimizing the use of CROs by academia and small companies

Rachel F. Lane
, Lauren G. Friedman
, Curtis Keith
, Steven P. Braithwaite
, Julie A. Frearson
, David A. Lowe
, Frank M. Longo
, Lorenzo M. Refolo
, D. Martin Watterson
, Katya Tsaioun
, Diana W. Shineman
, Howard M. Fillit

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Original language	English
Pages (from-to)	487-488
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	12
Issue number	7
DOIs	https://doi.org/10.1038/nrd4057
State	Published - Jul 2013
Externally published	Yes

Access to Document

10.1038/nrd4057

Cite this

@article{b5b87d8160324d029c0ea966e7b4e125,

title = "Optimizing the use of CROs by academia and small companies",

author = "Lane, \{Rachel F.\} and Friedman, \{Lauren G.\} and Curtis Keith and Braithwaite, \{Steven P.\} and Frearson, \{Julie A.\} and Lowe, \{David A.\} and Longo, \{Frank M.\} and Refolo, \{Lorenzo M.\} and Watterson, \{D. Martin\} and Katya Tsaioun and Shineman, \{Diana W.\} and Fillit, \{Howard M.\}",

year = "2013",

month = jul,

doi = "10.1038/nrd4057",

language = "English",

volume = "12",

pages = "487--488",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "7",

}

TY - JOUR

T1 - Optimizing the use of CROs by academia and small companies

AU - Lane, Rachel F.

AU - Friedman, Lauren G.

AU - Keith, Curtis

AU - Braithwaite, Steven P.

AU - Frearson, Julie A.

AU - Lowe, David A.

AU - Longo, Frank M.

AU - Refolo, Lorenzo M.

AU - Watterson, D. Martin

AU - Tsaioun, Katya

AU - Shineman, Diana W.

AU - Fillit, Howard M.

PY - 2013/7

Y1 - 2013/7

UR - https://www.scopus.com/pages/publications/84879665511

U2 - 10.1038/nrd4057

DO - 10.1038/nrd4057

M3 - Comment/debate

C2 - 23812255

AN - SCOPUS:84879665511

SN - 1474-1776

VL - 12

SP - 487

EP - 488

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 7

ER -